Comprehensive guide to Pharmaceutical Patents cases, courts, and legal analysis.
This case involves a patent dispute between Ascendis Pharma A/S and Biomarin Pharmaceutical Inc. regarding a drug used to treat achondroplasia, a form of dwarfism. Ascendis sued Biomarin, alleging tha...
Colage v. Collins, decided by Federal Circuit on December 3, 2025, resulted in a plaintiff win outcome. The case concerns the patentability of a "method of treatment" claim for a patented drug. The Fe...
Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., decided by Federal Circuit on September 23, 2025, resulted in a defendant win outcome. The core dispute involved the validity of a patent...
Acorda Therapeutics, Inc. v. Alkermes Plc, decided by Federal Circuit on July 25, 2025, resulted in a defendant win outcome. The Federal Circuit affirmed the district court's grant of summary judgment...
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., decided by Federal Circuit on July 8, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Teva Pharmaceutic...
Merck Sharp & Dohme B v. v. Aurobindo Pharma USA, Inc., decided by Federal Circuit on March 13, 2025, resulted in a defendant win outcome. The core dispute centered on whether Merck's patent for its b...
AI-generated summary for informational purposes only. Not legal advice. May contain errors. Consult a licensed attorney for legal advice.